US2020325190A1PendingUtilityA1

Modification and Compositions of Human Secretoglobin Proteins

Assignee: PILON CLAYTON APRILE LPriority: Mar 15, 2013Filed: Jun 9, 2020Published: Oct 15, 2020
Est. expiryMar 15, 2033(~6.7 yrs left)· nominal 20-yr term from priority
A61K 38/1709C07K 14/47C12P 21/00
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Novel compositions of recombinant human CC10 protein have been generated by chemically modifying the pure protein in vitro. Several new synthetic preparations containing isoforms of chemically modified rhCC10 have been generated by processes that utilize reactive oxygen species and reactive nitrogen species. These preparations contain novel isoforms of rhCC10 which have been characterized with enhanced or altered biological properties compared to the unmodified protein. Preparations containing novel isoforms may be used as standards to identify and characterize naturally occurring isoforms of native CC10 protein from blood or urine and ultimately to measure new CC10-based biomarkers to assess patient disease status. These preparations may also be used to treat respiratory, autoimmune, inflammatory, and other medical conditions that are not effectively treated with the unmodified protein.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A composition of matter comprising a chemically or enzymatically oxidized synthetic secretoglobin having one or more modified amino acids. 
     
     
         2 . The composition of  claim 1  wherein the chemically or enzymatically oxidized synthetic secretoglobin has one or more methionine sulfoxides. 
     
     
         3 . The composition of  claim 1  wherein the chemically or enzymatically oxidized synthetic secretoglobin has one or more nitrotyrosines, chlorotyrosines, or di-tyrosines. 
     
     
         4 . The composition of  claim 1  wherein the chemically or enzymatically oxidized synthetic secretoglobin has one or more cysteine glutathiolates or HNE-cysteines. 
     
     
         5 . The composition of  claim 1  wherein the chemically or enzymatically oxidized synthetic secretoglobin has one or more carbonyl groups. 
     
     
         6 . The composition of  claim 1  wherein the chemically or enzymatically oxidized synthetic secretoglobin has one or more hydroxyprolines or pyrrolidones. 
     
     
         7 . The composition of  claim 1  wherein the chemically or enzymatically oxidized synthetic secretoglobin has one or more α-aminoadipic semialdehyde, chloramines, MDA-Lys, HNE-Lys, acrolein-Lys, carboxymethyllysine, or pHA-Lys. 
     
     
         8 . The composition of  claim 1  wherein the chemically or enzymatically oxidized synthetic secretoglobin has one or more 2-amino-3-ketobutyric acids, chloramines, hydroxytryptophan, nitro-tryptophan, kynurenines, valine or leucine peroxides, oxalic or pyruvic acids, hydroxyphenylalanines 2-oxohistidine or HNE-His. 
     
     
         9 . The composition of  claim 1  wherein the chemically or enzymatically oxidized synthetic secretoglobin has one or more labels, chemicals, lipids, or peptides attached to a glutamine or lysine residue. 
     
     
         10 . A composition of matter comprising a chemically or enzymatically oxidized synthetic CC10 having one or more modified amino acids. 
     
     
         11 . The composition of  claim 10  wherein the chemically or enzymatically oxidized synthetic CC10 has one or more methionine sulfoxides. 
     
     
         12 . The composition of  claim 10  wherein the chemically or enzymatically oxidized synthetic CC10 has one or more nitrotyrosines, chlorotyrosines, or di-tyrosines. 
     
     
         13 . The composition of  claim 10  wherein the chemically or enzymatically oxidized synthetic CC10 has one or more cysteine glutathiolates or HNE-cysteines. 
     
     
         14 . The composition of  claim 10  wherein the chemically or enzymatically oxidized synthetic CC10 has one or more carbonyl groups. 
     
     
         15 . The composition of  claim 10  wherein the chemically or enzymatically oxidized synthetic CC10 has one or more hydroxyprolines or pyrrolidones. 
     
     
         16 . The composition of  claim 10  wherein the chemically or enzymatically oxidized synthetic CC10 has one or more hydroxyprolines or pyrrolidones. 
     
     
         17 . The composition of  claim 10  wherein the chemically or enzymatically oxidized synthetic CC10 has one or more α-aminoadipic semialdehyde, chloramines, MDA-Lys, HNE-Lys, acrolein-Lys, carboxymethyllysine, or pHA-Lys. 
     
     
         18 . The composition of  claim 10  wherein the chemically or enzymatically oxidized synthetic CC10 has one or more 2-amino-3-ketobutyric acids, chloramines, valine or leucine peroxides, oxalic or pyruvic acids, or hydroxyphenylalanines. 
     
     
         19 . The composition of  claim 10  wherein the chemically or enzymatically oxidized synthetic CC10 has one or more labels, chemicals, lipids, or peptides attached to a glutamine or lysine residue.

Join the waitlist — get patent alerts

Track US2020325190A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.